Zydus launches Topiramate Extended-Release Capsules
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The only definitive way to diagnose and stage lung cancers is through biopsies
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Subscribe To Our Newsletter & Stay Updated